- Home
- CTS vs KNSA Comparison
CTS vs KNSA Comparison
Compare CTS & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTS
- KNSA
- Stock Information
- Founded
- CTS 1896
- KNSA 2015
- Country
- CTS United States
- KNSA United Kingdom
- Employees
- CTS N/A
- KNSA N/A
- Industry
- CTS Electrical Products
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- CTS Technology
- KNSA Health Care
- Exchange
- CTS Nasdaq
- KNSA Nasdaq
- Market Cap
- CTS 1.6B
- KNSA 1.3B
- IPO Year
- CTS N/A
- KNSA 2018
- Fundamental
- Price
- CTS $48.19
- KNSA $18.92
- Analyst Decision
- CTS Hold
- KNSA Strong Buy
- Analyst Count
- CTS 1
- KNSA 5
- Target Price
- CTS $46.00
- KNSA $36.60
- AVG Volume (30 Days)
- CTS 127.5K
- KNSA 557.8K
- Earning Date
- CTS 02-04-2025
- KNSA 02-26-2025
- Dividend Yield
- CTS 0.34%
- KNSA N/A
- EPS Growth
- CTS N/A
- KNSA N/A
- EPS
- CTS 1.89
- KNSA N/A
- Revenue
- CTS $515,770,999.00
- KNSA $384,098,000.00
- Revenue This Year
- CTS N/A
- KNSA $60.10
- Revenue Next Year
- CTS $5.85
- KNSA $36.31
- P/E Ratio
- CTS $24.94
- KNSA N/A
- Revenue Growth
- CTS N/A
- KNSA 54.41
- 52 Week Low
- CTS $42.20
- KNSA $16.56
- 52 Week High
- CTS $59.68
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- CTS 28.20
- KNSA 42.61
- Support Level
- CTS $44.00
- KNSA $18.47
- Resistance Level
- CTS $52.39
- KNSA $20.90
- Average True Range (ATR)
- CTS 1.34
- KNSA 0.72
- MACD
- CTS -0.41
- KNSA -0.01
- Stochastic Oscillator
- CTS 32.22
- KNSA 24.71
About CTS CTS Corporation
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan and other countries.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.